Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WAY 163909

Known as: WAY-163909, WAY163909 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ABSTRACT Serotonin2C receptor (5‐HT2C) agonists are promising drugs for the treatment of neuropsychiatric diseases. However… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
Intensification of craving elicited by drug-associated cues during abstinence occurs over time in human cocaine users while… Expand
  • figure 1
  • figure 2
  • figure 3
2014
2014
Cocaine dependence remains a challenging public health problem with relapse cited as a major determinant in its chronicity and… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2013
Highly Cited
2013
Relapse to cocaine dependence, even after extended abstinence, involves a number of liability factors including impulsivity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
The mechanism by which the psychostimulant methamphetamine (METH) increases locomotor activity may be attributable to indirect… Expand
  • figure 1
  • table 1
  • figure 8
Highly Cited
2008
Highly Cited
2008
Increased impulsivity is observed across a number of neuropsychiatric and neurodegenerative diseases. Preclinical evidence has… Expand
2008
2008
Introduction5-HT2C agonists, by decreasing mesolimbic dopamine without affecting nigrostriatal dopamine, are predicted to have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Highly Cited
2007
Highly Cited
2007
RationaleActivation of one or more of the serotonin (5-HT) receptors may play a role in mediating the antidepressant effects of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2005
Highly Cited
2005
The pharmacological profile of WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi… Expand